El.En. Group Valuation Multiples

El.En. Group is valued at $1.4B as of October 2026, a 2.0x revenue multiple. In the last 12 months, El.En. Group revenue was $588M and El.En. Group EBITDA was $112M.

El.En. Group Overview

About El.En. Group

El.En. Group is an Italian maker of laser sources and laser systems, founded in Florence in 1981 and headquartered in Calenzano. It is listed on the Euronext STAR Milan segment under the ticker ELN. The group designs, produces and sells lasers for medical and aesthetic use in dermatology, surgery, physiotherapy, dentistry and gynaecology, for industrial applications such as cutting, marking and welding of metals and other materials, and for the conservation of works of art. Its medical and aesthetic operations include DEKA, Asclepion and Quanta System, and its industrial operations include Cutlite Penta. It reported turnover of 591 million euros and EBITDA of 93 million euros for 2025. The group has grown by acquiring laser companies in Italy, Germany and the United States, sold a majority of Penta Laser Zhejiang to a Chinese buyer in 2025 and agreed in August 2026 to sell 80 percent of its laser cutting business to Trumpf.


Founded

1981

HQ

Italy

Employees

1.4K

Financials (LTM)

Revenue: $588M
EBITDA: $112M

EV

$1.2B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

El.En. Group Financials

El.En. Group reported last 12-month revenue of $588M and EBITDA of $112M.

In the same LTM period, El.En. Group generated $112M in EBITDA and $65M in net income.

Revenue (LTM)


El.En. Group P&L

In the most recent fiscal year, El.En. Group reported revenue of $663M and EBITDA of $93M.

El.En. Group is profitable as of last fiscal year, with gross margin of 43%, EBITDA margin of 14%, and net margin of 7%.

See analyst estimates for El.En. Group
LTMLast FY202320242025202620272028
Revenue$588M$663M$801M$655M$663M
Gross Profit-$285M$294M$276M$285M
Gross Margin-43%37%42%43%
EBITDA$112M$93M$97M$113M$93M
EBITDA Margin19%14%12%17%14%
EBIT Margin17%12%10%13%12%
Net Profit$65M$49M$56M$60M$49M
Net Margin11%7%7%9%7%
Net Debt-($165M)---

Financial data powered by Morningstar, Inc.

El.En. Group Stock Performance

El.En. Group has current market cap of $1.4B, and enterprise value of $1.2B.

Market Cap Evolution


El.En. Group's stock price is $17.31.

El.En. Group share price decreased by 6.7% in the last 30 days, and increased by 31.7% in the last year.

El.En. Group has an EPS (earnings per share) of $0.61.

See more trading valuation data for El.En. Group
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1.2B$1.4B0.3%-6.7%-3.5%31.7%$0.61

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

El.En. Group Valuation Multiples

El.En. Group trades at 2.0x EV/Revenue multiple, and 10.7x EV/EBITDA.

See NTM and 2027E valuation multiples for El.En. Group

EV / Revenue (LTM)


El.En. Group Financial Valuation Multiples

As of October 22, 2026, El.En. Group has market cap of $1.4B and EV of $1.2B.

El.En. Group has a P/E ratio of 21.5x.

LTMLast FY202320242025202620272028
EV/Revenue2.0x1.8x1.5x1.8x1.8x
EV/EBITDA10.7x12.9x12.3x10.6x12.9x
EV/EBIT12.1x14.8x15.7x14.4x14.8x
EV/Gross Profit-4.2x4.1x4.3x4.2x
P/E21.5x28.5x24.9x23.3x28.5x
EV/FCF16.8x18.0xn/m14.1x18.0x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified El.En. Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

El.En. Group Margins & Growth Rates

El.En. Group decreased revenue by 14% but EBITDA grew by 22% in the last fiscal year.

In the most recent fiscal year, El.En. Group reported gross margin of 43%, EBITDA margin of 14%, and net margin of 7%.

See estimated margins and future growth rates for El.En. Group

El.En. Group Margins

Last FY202420252026202720282029
Gross Margin43%42%43%-
EBITDA Margin14%17%14%20%
EBIT Margin12%13%12%18%
Net Margin7%9%7%12%
FCF Margin10%13%10%13%

El.En. Group Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(14%)(18%)1%(14%)
Gross Profit Growth-(6%)3%-
EBITDA Growth22%16%(17%)22%
EBIT Growth25%9%(2%)25%
Net Profit Growth39%7%(18%)39%
FCF Growth8%(6530%)(22%)8%

Data powered by FactSet, Inc. and Morningstar, Inc.

El.En. Group Operational KPIs

El.En. Group's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.1M for the same period.

El.En. Group's Rule of 40 is 6% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

El.En. Group's Rule of X is (16%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for El.En. Group
LTMLast FY202320242025202620272028
Rule of 4021%6%---
Bessemer Rule of X24%(16%)---
Revenue per Employee-$0.5M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue-2%2%2%2%
G&A Expenses to Revenue-2%1%2%2%
Opex to Revenue-31%27%30%31%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

El.En. Group Competitors

El.En. Group competitors include Sinocare, Sansure Biotech, Conmed, Medartis, Vitrolife, Nakanishi, Weigao Group, Beijing Balance Medical, VCANBIO and Alpha Tau Medical.

Most El.En. Group public comparables operate across Medical Devices, DeepTech and HealthTech.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Sinocare$698M$43M2.0x1.9x32.9x15.6x
Sansure Biotech$246M$49M4.2x4.1x21.4x14.3x
Conmed$1.4B$176M1.6x1.6x12.5x7.9x
Medartis$326M$54M4.8x4.0x29.3x22.3x
Vitrolife$347M($445M)4.1x4.0x(3.2x)12.6x
Nakanishi$513M$53M2.5x2.2x24.7x8.5x
Weigao Group$228M$56M4.8x4.6x19.5x14.1x
Beijing Balance Medical$93M$37M15.8x-39.6x-

This data is available for Pro users. Sign up to see all El.En. Group competitors and their valuation data.

Start Free Trial

Acquisitions by El.En. Group

El.En. Group has acquired 3 companies to date.

Last acquisition by El.En. Group was on January 1st 2005. El.En. Group acquired ASA for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by El.En. Group

ASA
Quanta System
Asclepion Laser Technologies
Description
ASA S.r.l. is an Italian company in the medical and aesthetic laser sector that joined the El.En. group in 2005. The group names it among its companies active in the medical and aesthetic sector, together with DEKA, Asclepion and Quanta System, each aimed at its specific markets. As part of El.En., a laser group founded in Florence in 1981 and listed on the Milan exchange since December 2000, ASA is a subsidiary of that group. The El.En. group reported turnover of 591 million euros in 2025 across its medical, industrial and restoration laser activities.
Quanta System is an Italian laser maker that El.En. acquired in 2004 and owned in full by 2014. It is one of the group's medical and aesthetic companies, together with DEKA, Asclepion and ASA. Its aesthetic medical line is sold in North America through the distributor Quanta Aesthetic Lasers USA, which was allowed to use the Quanta System name. By 2014 the partnership with that distributor was among the fastest growing in the US aesthetic laser market, with the distributor posting sales of 6.8 million dollars in 2013. The parent group, founded in Florence in 1981, reported turnover of 591 million euros in 2025 and sells laser systems worldwide.
Asclepion Laser Technologies is a German manufacturer of medical and aesthetic laser systems. It joined El.En. in 2003 and is one of the group's companies active in the medical and aesthetic sector, together with DEKA, ASA and Quanta System. The group says these companies each focus on their specific markets. Asclepion Laser Technologies GmbH makes laser systems for the medical and aesthetic sector. El.En., the parent, was founded in Florence in 1981 and sells in North America, Europe, China and Japan. The parent reported turnover of 591 million euros in 2025.
HQ CountryItalyItalyGermany
HQ City
-
-
-
Deal Date1 Jan 20051 Jan 20041 Jan 2003
Valuationundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all El.En. Group acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by El.En. Group

El.En. Group has invested in 2 companies to date.

Latest investment by El.En. Group was on August 1st 2014. El.En. Group invested in Quanta Aesthetic Lasers USA in their $2M Strategic investment round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by El.En. Group

Quanta Aesthetic Lasers USA
Cynosure
Description
Quanta Aesthetic Lasers USA, known as Quanta USA, is an independent American company that was allowed by the El.En. group to use the Quanta System name as its exclusive distributor in North America for the aesthetic medical line. It is a limited liability company. In 2013, its third year of collaboration with Quanta System, it recorded sales of 6.8 million dollars and EBIT of about 450 thousand dollars, and it booked 4.9 million dollars of sales in the first six months of 2014. Its partnership with Quanta System, a wholly owned El.En. subsidiary, made it one of the fastest growing players in the US aesthetic medicine laser market at the time of the investment.
Cynosure is a Westford, Massachusetts-headquartered manufacturer of laser and light-based systems for aesthetic and medical treatments. Acquired by Hologic in 2017, its devices treat hair removal, skin resurfacing, vascular conditions, and scars using technologies like PicoSure and Elite IQ. Cynosure distributes to dermatologists and clinics globally, with manufacturing in the United States and sales offices in Europe and Asia.
HQ CountryUnited StatesUnited States
HQ City
-
Lowell, MA
Deal Date1 Aug 20141 Jan 2002
RoundStrategic investmentStrategic investment
Raised$2Mundisclosed
InvestorsEl.En. GroupEl.En. Group
Valuation$12Mundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all El.En. Group investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About El.En. Group

When was El.En. Group founded?El.En. Group was founded in 1981.
Where is El.En. Group headquartered?El.En. Group is headquartered in Italy.
How many employees does El.En. Group have?As of today, El.En. Group has over 1K employees.
Who is the CEO of El.En. Group?El.En. Group's CEO is Gabriele Clementi.
Is El.En. Group publicly listed?Yes, El.En. Group is a public company listed on Borsa Italiana.
What is the stock symbol of El.En. Group?El.En. Group trades under ELN ticker.
When did El.En. Group go public?El.En. Group went public in 2000.
Who are competitors of El.En. Group?El.En. Group main competitors include Sinocare, Sansure Biotech, Conmed, Medartis, Vitrolife, Nakanishi, Weigao Group, Beijing Balance Medical, VCANBIO, Alpha Tau Medical.
What is the current market cap of El.En. Group?El.En. Group's current market cap is $1.4B.
What is the current revenue of El.En. Group?El.En. Group's last 12 months revenue is $588M.
What is the current revenue growth of El.En. Group?El.En. Group revenue growth (NTM/LTM) is 2%.
What is the current EV/Revenue multiple of El.En. Group?Current revenue multiple of El.En. Group is 2.0x.
What is the current EBITDA of El.En. Group?El.En. Group's last 12 months EBITDA is $112M.
What is El.En. Group's EBITDA margin?El.En. Group's last 12 months EBITDA margin is 19%.
What is the current EV/EBITDA multiple of El.En. Group?Current EBITDA multiple of El.En. Group is 10.7x.
What is the current FCF of El.En. Group?El.En. Group's last 12 months FCF is $71M.
What is El.En. Group's FCF margin?El.En. Group's last 12 months FCF margin is 12%.
What is the current EV/FCF multiple of El.En. Group?Current FCF multiple of El.En. Group is 16.8x.
How many companies El.En. Group has acquired to date?As of October 2026, El.En. Group has acquired 3 companies.
What was the largest acquisition by El.En. Group?None of the M&A deals El.En. Group has completed have disclosed valuations.
What companies El.En. Group acquired?El.En. Group acquired ASA, Quanta System, and Asclepion Laser Technologies.
In how many companies El.En. Group has invested to date?As of October 2026, El.En. Group has invested in 2 companies.
What was the last El.En. Group investment?On 1st August 2014 El.En. Group invested in Quanta Aesthetic Lasers USA, participating in a $2M Strategic investment round at $12M valuation.
In what companies El.En. Group invested in?El.En. Group invested in Quanta Aesthetic Lasers USA and Cynosure.

See public comps similar to El.En. Group

Lists including El.En. Group

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial